471 related articles for article (PubMed ID: 24647346)
1. Valproate-induced hyperammonemia in juvenile ceroid lipofuscinosis (Batten disease).
Larsen EP; Ostergaard JR
Seizure; 2014 Jun; 23(6):429-34. PubMed ID: 24647346
[TBL] [Abstract][Full Text] [Related]
2. Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and management.
Chopra A; Kolla BP; Mansukhani MP; Netzel P; Frye MA
Gen Hosp Psychiatry; 2012; 34(3):290-8. PubMed ID: 22305367
[TBL] [Abstract][Full Text] [Related]
3. Valproate (VPA)-associated hyperammonemic encephalopathy independent of elevated serum VPA levels: 21 cases in China from May 2000 to May 2012.
Cheng M; Tang X; Wen S; Yue J; Wang H
Compr Psychiatry; 2013 Jul; 54(5):562-7. PubMed ID: 23246073
[TBL] [Abstract][Full Text] [Related]
4. Valproate-induced hyperammonemic encephalopathy.
Segura-Bruna N; Rodriguez-Campello A; Puente V; Roquer J
Acta Neurol Scand; 2006 Jul; 114(1):1-7. PubMed ID: 16774619
[TBL] [Abstract][Full Text] [Related]
5. Incidence, Presentation, and Risk Factors for Sodium Valproate-Associated Hyperammonemia in Neurosurgical Patients: A Prospective, Observational Study.
Woo PYM; Woo AWY; Lam SW; Ko NMW; Ho JWK; Chu ACH; Kwan MCL; Chan Y; Wong HT; Chan KY
World Neurosurg; 2020 Dec; 144():e597-e604. PubMed ID: 32916358
[TBL] [Abstract][Full Text] [Related]
6. Serum and CSF glutamine levels in valproate-related hyperammonemic encephalopathy.
Vossler DG; Wilensky AJ; Cawthon DF; Kraemer DL; Ojemann LM; Caylor LM; Morgan JD
Epilepsia; 2002 Feb; 43(2):154-9. PubMed ID: 11903461
[TBL] [Abstract][Full Text] [Related]
7. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
Hamed SA; Abdella MM
Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
[TBL] [Abstract][Full Text] [Related]
8. Valproate-Induced Hyperammonemic Encephalopathy in General Hospital Patients With One or More Psychiatric Disorders.
Lewis C; Tesar GE; Dale R
Psychosomatics; 2017; 58(4):415-420. PubMed ID: 28411969
[TBL] [Abstract][Full Text] [Related]
9. Risk factors of hyperammonemia in epilepsy patients with valproic acid therapy.
Kwack DW; Kim DW
Clin Neurol Neurosurg; 2023 Oct; 233():107962. PubMed ID: 37717359
[TBL] [Abstract][Full Text] [Related]
10. Valproate-induced hyperammonemic encephalopathy.
Verrotti A; Trotta D; Morgese G; Chiarelli F
Metab Brain Dis; 2002 Dec; 17(4):367-73. PubMed ID: 12602513
[TBL] [Abstract][Full Text] [Related]
11. Valproate-induced hyperammonemic encephalopathy: a brief review.
Lewis C; Deshpande A; Tesar GE; Dale R
Curr Med Res Opin; 2012 Jun; 28(6):1039-42. PubMed ID: 22587482
[TBL] [Abstract][Full Text] [Related]
12. [The decreased level of plasma carnitine in patients with epilepsy].
Belousova ED
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):106-110. PubMed ID: 28745680
[TBL] [Abstract][Full Text] [Related]
13. Valproate-induced hyperammonemic encephalopathy in a renal transplanted patient.
Melexopoulou C; Marinaki S; Darema M; Skalioti C; Efthimiou A; Zavos G; Boletis JN
Ren Fail; 2014 Jul; 36(6):955-6. PubMed ID: 24665854
[TBL] [Abstract][Full Text] [Related]
14. Valproate Induced Hyperammonemic Encephalopathy.
Qayyum W; Yousafzai ZA; Iqbal MS; Khan S; Amin QK; Shafiqs I
J Ayub Med Coll Abbottabad; 2022; 34(Suppl 1)(4):S1038-S1039. PubMed ID: 36550671
[TBL] [Abstract][Full Text] [Related]
15. Epilepsy and antiepileptic drug therapy in juvenile neuronal ceroid lipofuscinosis.
Aberg LE; Bäckman M; Kirveskari E; Santavuori P
Epilepsia; 2000 Oct; 41(10):1296-302. PubMed ID: 11051125
[TBL] [Abstract][Full Text] [Related]
16. [Valproate-associated hyperammonemic encephalopathy. Report of one case].
Young P; Finn BC; Alvarez F; Bruetman JE; Trimarchi H
Rev Med Chil; 2007 Nov; 135(11):1446-9. PubMed ID: 18259656
[TBL] [Abstract][Full Text] [Related]
17. Valproate-associated hyperammonemic encephalopathy.
Wadzinski J; Franks R; Roane D; Bayard M
J Am Board Fam Med; 2007; 20(5):499-502. PubMed ID: 17823470
[TBL] [Abstract][Full Text] [Related]
18. Valproate-induced hyperammonemic encephalopathy treated by hemodialysis.
Tsai MF; Chen CY
Ren Fail; 2008; 30(8):822-4. PubMed ID: 18791959
[TBL] [Abstract][Full Text] [Related]
19. Hyperammonemic encephalopathy induced by a combination of valproate and pivmecillinam.
Lokrantz CM; Eriksson B; Rosén I; Asztely F
Acta Neurol Scand; 2004 Apr; 109(4):297-301. PubMed ID: 15016014
[TBL] [Abstract][Full Text] [Related]
20. [Valproate-induced hyperammonemic encephalopathy in a neonate: treatment with carglumic acid].
Fernández Colomer B; Rekarte García S; García López JE; Pérez González C; Montes Granda M; Coto Cotallo GD
An Pediatr (Barc); 2014 Oct; 81(4):251-5. PubMed ID: 24315420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
